Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Solifenacin/tamsulosin
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Solifenacin 6mg / Tamsulosin 400microgram MR tab
0704010W0AAAAAA
|
Solifenacin/tamsulosin | Solifenacin/tamsulosin | Obstetrics, Gynaecology and Urinary-Tract Disorders | 9,475 |
|
Vesomni 6mg/0.4mg modified-release tablets
0704010W0BBAAAA
|
Vesomni | Solifenacin/tamsulosin | Obstetrics, Gynaecology and Urinary-Tract Disorders | 4,045 |
|
Vecit 6mg/0.4mg modified-release tablets
0704010W0BCAAAA
|
Vecit | Solifenacin/tamsulosin | Obstetrics, Gynaecology and Urinary-Tract Disorders | 3 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.